FDC LTD. - 531599 - Statement Of Investor Complaints For The Quarter Ended June 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 1120 Name of the Signatory :- Varsharani KatreDesignation :- Company Secretary and Compliance Officer FDC LTD. - 531599 - Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
FDC Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here FDC LTD. - 531599 - Regulations 30 And 44(3) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations. 2015 ("Listing Regulations")
This is to inform you that pursuant to the provisions of Section 110 of the Companies Act, 2013, Act"}, read with the Companies (Management and Administration) Rules, 2014 (as amended from time to time) and other applicable provisions of the Act, the consent of the Members of the Company was sought through Postal Ballot for granting of Loan to Fair Deal Pharmaceuticals SA (PTY) LTD ("FDC SA"), A subsidiary Company by way of Special Resolution as contained in the Postal Ballot Notice dated June 10, 2022. In terms of Regulation 44 (3) of the Listing Regulations, please find enclosed herewith the details of Voting Results of the Postal Ballot conducted through remote e-voting process, in respect of the resolution contained in the said Postal Ballot Notice together with the Scrutiniser''s Report on the remote e-voting, issued by Mr. Sanjay Dholakia, Proprietor -Mis. Sanjay Dholakia & Associates, Practicing Company Secretaries. Pursuant to the Scrutiniser''s Report. FDC LTD. - 531599 - Closure of Trading Window
Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 & Amendments thereon and in compliance with Company''s Code of Conduct for the Prevention of Insider Trading and Code of Fair Disclosure, the Trading Window for dealing in Securities of the Company for all the Designated Persons, Connected Persons and their Immediate Relative(s), shall remain closed from Friday, July 01, 2022 until 48 hours after the declaration of the Unaudited Financial Results of the Company for the quarter ending June 30, 2022. The date of Board Meeting of the Company for consideration and approval of the Unaudited Financial Results for the quarter ending June 30, 2022 will be intimated in due course. Kindly take the same on record.
Glenmark Pharma launches first FDC drug Indamet for asthma patients
Glenmark Pharmaceuticals on Thursday said it has launched a novel fixed-dose combination (FDC) drug in the country for patients with uncontrolled asthma. The Mumbai-based drug major has launched - Indacaterol + Mometasone FDC under the brand name Indamet. The drug will be available in three strengths with a fixed dose of Indacaterol 150 mcg and variable doses of Mometasone 80 mcg, 160 mcg and 320 mcg to be taken once daily. "Respiratory is a key focus area for Glenmark, and the company leads from the front in providing access to the latest treatment options to patients. "We are proud to introduce this novel fixed-dose combination Indamet, which is the first of its kind in India, offering an affordable treatment option to both adults and adolescents 12 years of age and older suffering from uncontrolled asthma," Glenmark Pharmaceuticals Group Vice President & Head (India Formulations) Alok Malik said in a statement. The drug maker is the first company in India to market the FDC of . FDC LTD. - 531599 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Notice of Postal Ballot - Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations') FDC LTD. - 531599 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Dear Sir/Madam, Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we have received information of loss / theft of share certificates and request for issue of duplicate share certificate. We have processed for issue of duplicate share certificate through Registrar & Share Transfer Agent (RTAs) FDC LTD. - 531599 - Disclosure Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations. 2015
Dear Sir/Madam, Pursuant to Regulation 23(9) of the SEBI Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Disclosure of Related Party Transactions for the half year ended March 31, 2022. Kindly take the same on record. FDC LTD. - 531599 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio Recordings of the Q4 and FY 2022 Results Earnings Conference Call held on May 27, 2022. FDC LTD. - 531599 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of Q4 & FY22 Results Earnings Conference Call held on May 27, 2022